microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges

Published:2020-12-01 Issue:12 Volume:39 Page:2103-2124
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Kumar Vivek¹,Gupta Sameer²,Varma Kachnar³,Sachan Manisha¹

Affiliation:

1. Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, India.

2. Department of Surgical Oncology, King George Medical University, Lucknow, India.

3. Department of Pathology, Motilal Nehru Medical College, Allahabad, India.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2020.6024

Reference173 articles.

1. Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

2. Aberrant Regulation and Function of MicroRNAs in Cancer

3. The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas

4. Circulating microRNA expression profiles in ovarian cancer

5. Reactivity of a monoclonal antibody with human ovarian carcinoma.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative transcriptomic study on the ovarian cancer between chicken and human;Poultry Science;2024-09

2. The Role of Long Non-Coding RNF144A-AS1 in Cancer Progression;Cell Biochemistry and Biophysics;2024-07-16

3. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer;International Journal of Molecular Sciences;2024-03-28

4. Unraveling the microRNAs, key players in folliculogenesis and ovarian diseases;Middle East Fertility Society Journal;2024-03-01

5. Impact of three miRNA signature as potential diagnostic marker for triple negative breast cancer patients;Scientific Reports;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3